DENTSPLY SIRONA Inc. $XRAY Shares Acquired by Fifth Third Bancorp

Fifth Third Bancorp lifted its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 6.0% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 31,113 shares of the medical instruments supplier’s stock after acquiring an additional 1,750 shares during the period. Fifth Third Bancorp’s holdings in DENTSPLY SIRONA were worth $494,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the stock. Gabelli Funds LLC boosted its stake in shares of DENTSPLY SIRONA by 1.0% during the first quarter. Gabelli Funds LLC now owns 98,000 shares of the medical instruments supplier’s stock valued at $1,464,000 after acquiring an additional 1,000 shares during the last quarter. Empowered Funds LLC boosted its stake in DENTSPLY SIRONA by 8.8% in the 1st quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier’s stock worth $244,000 after buying an additional 1,320 shares during the last quarter. Covestor Ltd boosted its stake in DENTSPLY SIRONA by 17.5% in the 1st quarter. Covestor Ltd now owns 9,778 shares of the medical instruments supplier’s stock worth $146,000 after buying an additional 1,456 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new stake in DENTSPLY SIRONA in the 1st quarter worth about $25,000. Finally, Principal Financial Group Inc. boosted its stake in DENTSPLY SIRONA by 0.4% in the 1st quarter. Principal Financial Group Inc. now owns 457,397 shares of the medical instruments supplier’s stock worth $6,834,000 after buying an additional 1,708 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Trading Up 0.9%

NASDAQ:XRAY opened at $12.61 on Tuesday. DENTSPLY SIRONA Inc. has a 12-month low of $12.14 and a 12-month high of $27.16. The firm has a market capitalization of $2.52 billion, a P/E ratio of -2.66, a P/E/G ratio of 0.78 and a beta of 0.96. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The business has a 50 day simple moving average of $14.08 and a 200 day simple moving average of $14.79.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The business had revenue of $936.00 million during the quarter, compared to analyst estimates of $929.67 million. During the same quarter in the previous year, the firm posted $0.49 EPS. The business’s revenue for the quarter was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Equities research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 10th. Investors of record on Friday, September 26th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, September 26th. This represents a $0.64 dividend on an annualized basis and a yield of 5.1%. DENTSPLY SIRONA’s payout ratio is currently -13.50%.

Analysts Set New Price Targets

A number of brokerages have issued reports on XRAY. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a research note on Friday. Wells Fargo & Company decreased their price target on DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating on the stock in a research note on Friday, August 8th. Wall Street Zen raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Friday. UBS Group cut their price objective on DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating on the stock in a report on Friday, August 8th. Finally, Stifel Nicolaus cut their price objective on DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating on the stock in a report on Friday, August 8th. Two analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $18.64.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.